Background Non-invasive prenatal testing (NIPT) is a widely adopted maternal blood test
that analyses foetal originating DNA to screen for foetal chromosomal conditions, including …

Non-invasive prenatal testing (NIPT) for trisomies 21, 18, 13 and monosomy X is widely
utilized with massively parallel shotgun sequencing (MPSS), digital analysis of selected …

Importance Ultrasonographic measurement of fetal nuchal translucency is used in prenatal
screening for trisomies 21 and 18 and other conditions. A cutoff of 3.5 mm or greater is …

Objective To determine the effects of alanine transaminase (ALT) levels on the screening
failure rates or “no calls” due to low fetal fraction (FF) to obtain a result in non-invasive …

Background Multiple marker screening is offered to pregnant individuals in many
jurisdictions to screen for trisomies 21 and 18. On occasion, the result is 'double-positive'—a …

Objectives To determine the cost-effectiveness of the addition of chromosomal anomalies
detectable by non-invasive prenatal screening (NIPS), in a prenatal screening programme …

Objective To review the available prenatal aneuploidy screening options and to provide
updated clinical guidelines for reproductive care providers. Target Population All pregnant …

Objectif Examiner les possibilités de dépistage prénatal des aneuploïdies et fournir des
lignes directrices cliniques actualisées aux prestataires de soins de la reproduction …

Неинвазивное пренатальное тестирование (НИПТ)-это молекулярно-генетическое
исследование, основанное на анализе внеклеточной фетоплацентарной ДНК в крови …

Non-invasive prenatal testing (NIPT) is a method of prenatal screening that became
available in approximately 2011. It uses fetal DNA in the maternal bloodstream to screen for …